Mark E. Dmytruk Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

Mark E. Dmytruk is Officer of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 33,963 shares of DNA, which is worth approximately $367,479. The most recent transaction as insider was on Feb 01, 2024, when has been sold 85,208 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34K

7.44% 3M change

95.54% 12M change

Total Value Held $367,479

Mark E. Dmytruk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2024	BUY Exercise of conversion of derivative security	-	85,208 Added 9.61%	801,306 Class A Common Stock
Jan 03 2024	SELL Open market or private sale	$70,522 $1.54 p/Share	45,794 Reduced 6.01%	716,098 Class A Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	-	85,048 Added 10.04%	761,892 Class A Common Stock
Dec 04 2023	SELL Open market or private sale	$58,938 $1.39 p/Share	42,402 Reduced 5.9%	676,844 Class A Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	-	85,040 Added 10.57%	719,246 Class A Common Stock
Nov 02 2023	SELL Open market or private sale	$55,843 $1.5 p/Share	37,229 Reduced 5.54%	634,206 Class A Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	-	85,042 Added 11.24%	671,435 Class A Common Stock
Oct 02 2023	SELL Open market or private sale	$74,337 $1.76 p/Share	42,237 Reduced 6.72%	586,393 Class A Common Stock
Oct 01 2023	BUY Exercise of conversion of derivative security	-	85,045 Added 11.92%	628,630 Class A Common Stock
Sep 05 2023	SELL Open market or private sale	$92,359 $2.23 p/Share	41,417 Reduced 7.08%	543,585 Class A Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	85,043 Added 12.69%	585,002 Class A Common Stock
Aug 02 2023	SELL Open market or private sale	$96,294 $2.07 p/Share	46,519 Reduced 8.51%	499,959 Class A Common Stock
Aug 01 2023	BUY Exercise of conversion of derivative security	-	85,046 Added 13.47%	546,478 Class A Common Stock
Jul 03 2023	SELL Open market or private sale	$73,146 $1.8 p/Share	40,637 Reduced 8.09%	461,432 Class A Common Stock
Jul 01 2023	BUY Exercise of conversion of derivative security	-	85,041 Added 14.48%	502,069 Class A Common Stock
Jun 02 2023	SELL Open market or private sale	$63,197 $1.56 p/Share	40,511 Reduced 8.85%	417,028 Class A Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	-	85,044 Added 15.67%	457,539 Class A Common Stock
May 22 2023	SELL Open market or private sale	$375,000 $1.5 p/Share	250,000 Reduced 40.16%	372,495 Class A Common Stock
May 02 2023	SELL Open market or private sale	$44,622 $1.15 p/Share	38,802 Reduced 5.87%	622,495 Class A Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	-	85,043 Added 11.39%	661,297 Class A Common Stock
Apr 10 2023	SELL Open market or private sale	$984 $1.33 p/Share	740 Reduced 0.13%	576,254 Class A Common Stock
Apr 06 2023	BUY Exercise of conversion of derivative security	-	1,636 Added 0.28%	576,994 Class A Common Stock
Apr 03 2023	SELL Open market or private sale	$49,259 $1.27 p/Share	38,787 Reduced 6.32%	575,358 Class A Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	83,409 Added 11.96%	614,145 Class A Common Stock
Mar 15 2023	SELL Open market or private sale	$38,988 $1.31 p/Share	29,762 Reduced 5.31%	530,736 Class A Common Stock

MED

Mark E. Dmytruk

Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Value

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA

Account